Skip to main content
ADCES 2026 Annual Conference Main banner

Equitable Care for Diverse Individuals and Populations

(D29) Optimizing Diabetes Management in Aging Adults: Smarter Care for a Changing Population

Sunday, August 9, 2026
3:45 PM - 4:30 PM ET
CE: .75 CE
Pharmacology Hours: .25 CE
This session addresses the complex clinical, functional, and safety challenges involved in managing diabetes in older adults. Drawing on the 2026 ADA Standards of Care and the American Geriatrics Society Beers Criteria, the session highlights individualized glycemic targets, comorbidity burden, hypoglycemia risk, cognitive decline, and medication safety. Practical strategies, including treatment plan simplification, time-in-range metrics, caregiver engagement, and CGM-informed decision-making, are emphasized. Through evidence-based discussion, participants will gain actionable approaches to improve outcomes, enhance safety, and support patient-centered diabetes care for older adults.

Learning Objectives:

At the completion of this activity, participants should be able to:
  • Describe key recommendations from the American Diabetes Association 2026 Standards of Care for diabetes in older adults.
  • Apply pharmacology, nutrition, and the Beers Criteria when managing care for older adults.
  • Proactively identify hypoglycemia and safety risks while incorporating Time in Range (TIR) as a key metric.
Disclosure(s):
Bantwal S. Baliga, M.D., M.R.C.P. (U.K): Abbott laboratories: Speakers' Bureau (Ongoing); Ascensia Diabetes Care: Consultant / Advisory Board (Ongoing); Boehringer Ingleheim Pharmaceuticals: Speakers' Bureau (Ongoing); Lilly USA: Speakers' Bureau (Ongoing)
Lisa B. Smith, DNP, FNP, BC-ADM, CDCES: No financial relationships to disclose

    Primary Presenter(s)

  • BB

    Bantwal S. Baliga, M.D., M.R.C.P. (U.K)

    Owner & CEO/Chief Endocrinologist
    East Alabama Endocrinology, P.C.

    Disclosure(s): Abbott laboratories: Speakers' Bureau (Ongoing); Ascensia Diabetes Care: Consultant / Advisory Board (Ongoing); Boehringer Ingleheim Pharmaceuticals: Speakers' Bureau (Ongoing); Lilly USA: Speakers' Bureau (Ongoing)

    • Co-Presenter(s)

  • Lisa B. Smith, DNP, FNP, BC-ADM, CDCES

    Nurse Pratitioner
    East Alabama Endocrinology, P.C.

    Disclosure(s): No financial relationships to disclose